Resveratrol could slow the progression of Alzheimer’s
A randomized, placebo controlled, double blind study explored the effects of high dose, long term use of resveratrol on amyloid-beta40 (Abeta40) which is a biomarker that decreases as the Alzheimer’s progresses in severity. Participants in the experimental group took 1g of oral resveratrol twice daily for 12 months. The experimental group showed little to no […]